Pay in 4 interest-free payments of $5.82 Learn more
Ships within 48 hours · Estimated delivery Oct 4 - Oct 9
Today Ely Lilly (LLY) announced the positive results on a phase 2 diabetes drug of theirs ( LY3298176 ) via a publication in The Lancet, a presentation at the annual meeting of the European Association for the Study of Diabetes (EASD) and the press release below: Lilly's Investigational Dual GIP and GLP-1 Receptor Agonist Shows Significant Reduction in HbA1c and Body Weight in People With Type 2 Diabetes The press release created a few headlines: Bloomberg: Diabetes Drug's Results Push Lilly to Look at Obesity Too Reuters: Lilly's diabetes drug data impresses, hurts rival Novo's shares The share price of Eli Lilly went up by 4% in an otherwise sour market and that of Danish rival Novo Nordisk (NOVO-B.CO) plummeted some 7-8%
Both GIP and GLP-1 are incretin hormones natural signals your body uses to regulate appetite, blood sugar, and energy balance
Is it explicitly labeled for research, or is it a cosmetic ingredient
10.15586/ijfs.v37i1.2787 Ital
Vitamin C is known for its skin benefits around the world and has become the staple of the beauty products and skin care regimen
Try these: Electrolyte packets (like LMNT, Liquid I.V., or Nuun) Broths or soups Coconut water Gatorade relyte Aim to sip fluids regularly throughout the day, not just when you feel thirsty
